The first company to take up residence in Bayer Co.Lab Berlin – initially located on the group's pharma headquarters site in ...

A strategy for women's health in England was published in 2022 under the previous Conservative government, led at the time by ...

In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control ...

In a statement, Applied Tx said it is reviewing the complete response letter (CRL) from the FDA and "plans to immediately ...

Healthcare professionals (HCPs) expect digital experiences to be as seamless and personalised as the apps and services they ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

“It’s a really exciting time, not just for NWEH, but also for the future of clinical trials in the UK. If successful, this ...

The company made its debut last year with a $51 million Series A and a licensing agreement with Astellas for a gene therapy ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

Great Place to Work, Built Ins: Top Biotech Companies 2024, Forbes Best Places to Work in Life Sciences are joining our LEAP ...

In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in ...

The European Commission has cleared use of CDK4/6 inhibitor Kisqali (ribociclib) to reduce the risk of recurrence in patients ...